UK Pharma Funding Rounds 2021

Every UK Pharma funding round filed in 2021, sourced direct from Companies House filings. Updated weekly.

UK Pharma Funding Rounds 2021

CompanyRaisedRoundDate
Stratosvir£140kSeed2026/02/12
Stingray Bio£200k-2022/10/04
Solascure£738k-2022/07/01
Regenall£110k-2022/06/29
Antev£12k-2022/03/24
Bivictrix Therapeutics£9.0M-2022/03/02
Jazz Pharmaceuticals Uk Holdings£480.7MShare swap, no new money-2022/01/26
Jazz Pharmaceuticals Uk Holdings£2253.1M-2022/01/26
Biocon Pharma Uk£300k-2022/01/24
Graegis Pharmaceuticals£1.9MSeries A2022/01/21
Grey Wolf Therapeutics£29.3M-2022/01/14
Psi Pharmaceuticals£10k-2021/12/29
Deplantis£200k-2021/12/22
Grow Group£718k-2021/12/22
Kanna Health£4.5M-2021/12/14
Monument Therapeutics£140k-2021/12/14
Monument Therapeutics£375k-2021/12/07
Gylden Pharma£3.7M-2021/12/06
Tangent 90£121k-2021/12/03
Carocell Bio£120k-2021/12/02
Solascure£8.1MCash and other non-cash consideration-2021/12/01
Senari Pharma£100k-2021/11/30
Medimab Biotherapeutics£200k-2021/11/29
Mitorx Therapeutics£1.6M-2021/11/26
Cs Pharmaceuticals£659k-2021/11/24

Sign up to see all uk pharma funding rounds 2021

+99 more rounds

Sign up

More Pharma funding